- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: UFOX Cetuximab
Total 3068 results
-
Ruijin HospitalHenan Cancer Hospital; Second Affiliated Hospital, School of Medicine, Zhejiang... and other collaboratorsUnknownColorectal Cancer
-
Eli Lilly and CompanyCompletedMetastatic Colorectal CancerSpain, United States, Canada
-
Merck KGaA, Darmstadt, GermanyCompleted
-
University of WashingtonMerck Sharp & Dohme LLCActive, not recruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
Nathan DenlingerBristol-Myers SquibbRecruitingB-Cell Non-Hodgkin Lymphoma-Recurrent | Diffuse Large B-Cell Lymphoma-Recurrent | Follicular Lymphoma-Recurrent | High Grade B-Cell Lymphoma-Recurrent | Primary Mediastinal Large B-Cell Lymphoma-Recurrent | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma-Recurrent and other conditionsUnited States
-
Fudan UniversityRecruitingColorectal Cancer | Liver MetastasesChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingRefractory Lymphoma | DLBCL | MYD88 Gene Mutation | Relapse | CD79A Gene Mutation | CD79B Gene Mutation
-
The Lymphoma Academic Research OrganisationRoche Pharma AGCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedMicroscopic Polyangiitis | Granulomatosis With Polyangiitis | Renal Limited FormsFrance
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Indolent Adult Non-Hodgkin... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Janssen, LPCompletedCD20 Positive | Ann Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Ann Arbor Stage II Marginal Zone Lymphoma | Ann Arbor Stage III Marginal... and other conditionsUnited States
-
mAbxience Research S.L.Laboratorio Elea Phoenix S.A.; Libbs Farmacêutica LTDA; Innogene Kalbiotech Pte... and other collaboratorsCompletedDiffuse Large B-cell LymphomaMalaysia, Argentina, Colombia, India, South Africa, Philippines, Brazil, Russian Federation, Indonesia, Iran, Islamic Republic of, Mexico, Paraguay
-
Kuopio University HospitalCompletedRheumatoid ArthritisFinland
-
University Health Network, TorontoAstraZeneca; NeoGenomics LaboratoriesRecruitingLocoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)Canada
-
AstraZenecaInnate PharmaActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States, France, Italy, Spain, Belgium, Canada, Taiwan, Switzerland, Korea, Republic of, Japan, Poland, Russian Federation, United Kingdom, Austria, Brazil, Germany, Netherlands, Portugal, Australia, Philippines, Bulgaria, G... and more
-
Nektar TherapeuticsCompletedCervical Cancer | Colorectal Cancer | Head and Neck Squamous Cell Carcinoma | Anal Squamous Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States
-
The Methodist Hospital Research InstituteBristol-Myers SquibbCompleted
-
Federation Francophone de Cancerologie DigestiveCompleted
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Non-small Cell Lung CancerChina
-
Washington University School of MedicineCompleted
-
Merck KGaA, Darmstadt, GermanyChoice Pharma TaiwanCompletedCarcinoma, Squamous Cell of Head and NeckTaiwan
-
AmgenCompletedArthritis, RheumatoidUnited States, Germany, Bulgaria, Hungary, Poland, Estonia
-
West China HospitalRecruitingBRAF V600E-mutated /MSS Metastatic Colorectal Cancer | Vemurafenib (BRAFi) Plus Cetuximab (EGFRi) Combined With PD-1 Monoclonal AntibodyChina
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Ludwig-Maximilians - University of MunichSanofi; Merck Sharp & Dohme LLC; Pfizer; Hoffmann-La RocheCompletedMetastatic Colorectal Cancer
-
Shandong Cancer Hospital and InstituteCancer Institute and Hospital, Chinese Academy of Medical Sciences; RenJi Hospital and other collaboratorsCompletedEsophageal CancerChina
-
National Cancer Institute (NCI)CompletedHead and Neck Squamous Cell Carcinoma | Recurrent Head and Neck CarcinomaUnited States
-
Eli Lilly and CompanyBristol-Myers SquibbCompletedNon-small Cell Lung CancerUnited States
-
Royal Marsden NHS Foundation TrustMerck Serono International SATerminated
-
Trisha Wise-DraperAstraZenecaActive, not recruitingHead and Neck Cancer | Head and Neck Neoplasms | Metastatic Cancer | Recurrent Head and Neck CancerUnited States
-
Hadassah Medical OrganizationMerck Serono International SATerminated
-
National Cancer Institute (NCI)CompletedColon Cancer | Colonic Neoplasms | Colonic Cancer | Cancer of the Colon | Colon NeoplasmsUnited States
-
NanoCarrier Co., Ltd.CompletedCarcinoma, Squamous Cell of Head and NeckUnited States, Hungary, Romania, Bulgaria
-
Merck KGaA, Darmstadt, GermanyMerck Ltd., IndiaTerminated
-
Swedish Medical CenterNovartis PharmaceuticalsCompletedStage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Adenocarcinoma of the Rectum | Adenocarcinoma of the ColonUnited States
-
Istituto Scientifico Romagnolo per lo Studio e...CompletedMetastatic Colorectal CancerItaly
-
Beijing HospitalBethune Charitable FoundationRecruitingICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRCMetastatic Colorectal Cancer | MSS | RAS MutationChina
-
Taiwan Leader Biotech Corp.Not yet recruitingAdvanced Colorectal Cancer
-
M.D. Anderson Cancer CenterGilead SciencesSuspendedSquamous Cell Carcinoma of Head and Neck | Head NeckUnited States
-
InventisBio Co., LtdMerck Sharp & Dohme LLCActive, not recruitingNSCLC | Solid Tumor, Adult | CRCUnited States, Taiwan, Australia, Korea, Republic of
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedHead and Neck Cancer | Precancerous ConditionUnited States
-
Memorial Sloan Kettering Cancer CenterCelgene Corporation; National Comprehensive Cancer NetworkCompleted
-
Shanghai Zhongshan HospitalRecruitingColorectal Neoplasms MalignantChina
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedSquamous Cell Carcinoma of the Skin | Recurrent Skin CancerUnited States
-
National Cancer Institute, NaplesCompletedAdvanced Non-Small Cell Lung CancerItaly
-
Narendranath EpperlaEli Lilly and CompanyNot yet recruitingMarginal Zone LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingNodular Lymphocyte Predominant B-Cell Lymphoma | Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma | Refractory Nodular Lymphocyte Predominant B-Cell LymphomaUnited States
-
Cliniques universitaires Saint-Luc- Université...Merck Sharp & Dohme LLCCompleted